Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study

NCT00848107 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT00848107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study
Lead sponsor
United Therapeutics
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2009
Completion date
September 30, 2011
Enrollment
115 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis